Decreasing Treatment Burdens with Second Generation Anti-VEGF Agents
Join John Kitchens, MD, and Michael Klufas, MD, to review pearls and data on the efficacy of next-generation anti-vascular endothelial growth factor (VEGF) drugs.
New Content
Parsing Risks and Finetuning Queries: Retina Research from GLP-1 to Curcumin
Eyes On Eyecare Site Sponsors
Resolving Neurotrophic Keratitis after Pars Plana Vitrectomy with Case Report
Review a case report to learn how ophthalmologists can treat neurotrophic keratitis (NK) secondary to pars plana vitrectomy.
Ongoing Challenges for Women in Ophthalmology
Learn about the obstacles women in ophthalmology face, tips from doctors on maneuvering these challenges, and organizations addressing these disparities.
The Benefits of Effective MD + OD Glaucoma Patient Management
Join Mitch Ibach, OD, and Preeya K. Gupta, MD as they discuss the many benefits of collaboration between ODs and MDs for the ongoing management of patients with glaucoma.
Topics
Decreasing Treatment Burdens with Second Generation Anti-VEGF Agents
Parsing Risks and Finetuning Queries: Retina Research from GLP-1 to Curcumin
Join John W Kitchens, MD, and Ehsan Rahimy, MD, to discuss new research in retina, such as GLP-1 receptor agonists and curcumin for inflammation.
Dry Eye Treatment in 2024: Keeping First Things First
Michael Garanzini, Senior Director of Marketing at Sun Pharma, and Crystal Brimer, OD, FAAO, discuss why focusing on the fundamentals of dry eye and why choosing CEQUA® (cyclosporine ophthalmic solution) 0.09% as your cyclosporine product can make all the difference in treating dry eye.
Resolving Neurotrophic Keratitis after Pars Plana Vitrectomy with Case Report
Review a case report to learn how ophthalmologists can treat neurotrophic keratitis (NK) secondary to pars plana vitrectomy.
Clinical Specialties
Sustaining Private Practice in a Consolidating Healthcare Market
Learn how co-owned MD/OD practices are the perfect answer for a sustaining private surgical practice in a consolidating healthcare market.
Ongoing Challenges for Women in Ophthalmology
Learn about the obstacles women in ophthalmology face, tips from doctors on maneuvering these challenges, and organizations addressing these disparities.
An MD-MBA Discusses the State of Private Ophthalmology Practice
Learn how ophthalmologists can overcome the largest obstacles in opening and maintaining a private practice to sustain long-term practice growth.
Careers
Which Is The Best Ophthalmology Residency For You?
Implementing EHRs in Eyecare with a Focus on Sustainability
Featured Writers
Become a Writer
Dry Eye Treatment in 2024: Keeping First Things First
Michael Garanzini, Senior Director of Marketing at Sun Pharma, and Crystal Brimer, OD, FAAO, discuss why focusing on the fundamentals of dry eye and why choosing CEQUA® (cyclosporine ophthalmic solution) 0.09% as your cyclosporine product can make all the difference in treating dry eye.
